B-Secur Receives ISO 13485:2016 Certification
BELFAST, Northern Ireland–(BUSINESS WIRE)–#BiosensingInnovation—B-Secur, a global leader in biosensing algorithms, today announced that it has... Read more.
Immunis Chairman Dr. Hans Keirstead to Present at the 2024 Biotech Showcase
IRVINE, Calif.–(BUSINESS WIRE)–#BIO—Immunis, Inc., a private biotech transforming the field of cellular secretome therapeutics, is excited to reveal... Read more.
Alliant Insurance Services Expands Employee Benefits Capabilities in Oregon by Acquiring Aldrich Benefits LP
Oregon-based benefits consultancy adds to Alliant’s reach in Oregon and Vancouver, Washington IRVINE, Calif.–(BUSINESS WIRE)–#AlliantInsurance—Alliant... Read more.
New Guidelines on Men with Erectile Dysfunction and Cardiac Health Published in the Journal of Sexual Medicine Concludes PDE-5 Inhibitors are Still Safe for the Cardiovascular System
PASADENA, Calif.–(BUSINESS WIRE)–25 years after Viagra hit the market, a group of experts from across the country examined the link between erectile... Read more.
Gilmore Bell Announces New Director and Shareholder in Salt Lake City
SALT LAKE CITY–(BUSINESS WIRE)–Gilmore & Bell, P.C., a leading public finance law firm, is pleased to announce that Clay Hardman has been named director... Read more.
Gilmore Bell Announces New Director in Kansas City
KANSAS CITY, Mo.–(BUSINESS WIRE)–Gilmore & Bell, P.C., a leading public finance law firm, is pleased to announce that Jason Schurke has been named... Read more.
Walgreens Boots Alliance Reports Fiscal 2024 First Quarter Results
Results In Line with Expectations; Executing in a Challenging Environment First quarter and recent financial highlights First quarter loss per share* was $0.08 compared... Read more.
To Unlock AI Innovation for Enterprise Sales and Marketing, ON24 Hosts Platform Launch Event
Thousands of B2B leaders will gather virtually at “ON24 Next” to unveil the next generation of ON24 and usher in a new era of intelligent engagement SAN FRANCISCO–(BUSINESS... Read more.
D-Wave Successfully Completes SOC 2 Type 2 Audit
Completion of SOC 2 Type 2 audit furthers company’s commitment to data security as customers adopt production use of its quantum computing solutions PALO ALTO,... Read more.
GlycoMimetics Announces Positive Initial Safety and Pharmacokinetic Results from Phase 1a Healthy Volunteer Study of GMI-1687
First in human trial evaluating highly potent E-selectin antagonist, GMI-1687, met its primary and secondary endpoints with no dose-limiting toxicities or safety... Read more.